Neuberger Berman Group LLC Alkermes Plc. Transaction History

Neuberger Berman Group LLC

  • $130 Billion
  • Q3 2025

A detailed history of Neuberger Berman Group LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 152,721 shares of ALKS stock, worth $4.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
152,721
Previous 196,331 22.21%
Holding current value
$4.44 Million
Previous $5.62 Million 18.44%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$26.13 - $30.46 $1.14 Million - $1.33 Million
-43,610 Reduced 22.21%
152,721 $4.58 Million
Q2 2025

Aug 13, 2025
SELL
$26.59 - $32.65 $96,947 - $119,041
-3,646 Reduced 1.82%
196,331 $5.62 Million
Q1 2025

May 13, 2025
BUY
$28.08 - $36.0 $5.27 Million - $6.76 Million
187,667 Added 1524.51%
199,977 $6.6 Million
Q4 2024

Feb 13, 2025
BUY
$25.7 - $31.46 $2,852 - $3,492
111 Added 0.91%
12,310 $354,000
Q3 2024

Nov 14, 2024
SELL
$23.01 - $28.55 $45,513 - $56,471
-1,978 Reduced 13.95%
12,199 $341,000
Q2 2024

Nov 14, 2024
BUY
$23.21 - $27.24 $127,330 - $149,438
5,486 Added 63.12%
14,177 $341,000
Q2 2024

Aug 13, 2024
BUY
$23.21 - $27.24 $127,330 - $149,438
5,486 Added 63.12%
14,177 $341,000
Q1 2024

Nov 14, 2024
SELL
$26.4 - $32.56 $6.61 Million - $8.16 Million
-250,547 Reduced 96.65%
8,691 $235,000
Q1 2024

May 13, 2024
BUY
$26.4 - $32.56 $229,442 - $282,978
8,691 New
8,691 $235,000
Q4 2023

Nov 14, 2024
BUY
$23.37 - $28.68 $5.73 Million - $7.03 Million
245,061 Added 1728.58%
259,238 $7.19 Million
Q4 2023

Feb 09, 2024
BUY
$23.37 - $28.68 $1.36 Million - $1.67 Million
58,399 Added 29.08%
259,238 $7.19 Million
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $37,331 - $43,926
1,374 Added 0.69%
200,839 $5.63 Million
Q2 2023

Aug 11, 2023
BUY
$28.34 - $33.63 $5.65 Million - $6.71 Million
199,465 New
199,465 $6.24 Million
Q4 2018

Feb 12, 2019
SELL
$27.94 - $44.61 $139,504 - $222,737
-4,993 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$38.6 - $46.12 $8,414 - $10,054
-218 Reduced 4.18%
4,993 $212,000
Q2 2018

Aug 13, 2018
SELL
$40.56 - $51.36 $200,772 - $254,232
-4,950 Reduced 48.72%
5,211 $214,000
Q1 2018

May 08, 2018
SELL
$53.61 - $67.26 $5,253 - $6,591
-98 Reduced 0.96%
10,161 $589,000
Q4 2017

Feb 14, 2018
SELL
$47.69 - $55.39 $4,625 - $5,372
-97 Reduced 0.94%
10,259 $561,000
Q3 2017

Nov 15, 2017
BUY
$49.16 - $54.45 $509,100 - $563,884
10,356
10,356 $526,000

Others Institutions Holding ALKS

# of Institutions
401
Shares Held
176M
Call Options Held
901K
Put Options Held
400K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.77B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email